• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Combined hepatocellular carcinoma-cholangiocarcinoma with sarcomatoid features: new insights into a rare and aggressive tumor.

作者信息

Ghaffar Sumaya Abdul, Ishida Aline Hikari, Gleisner Ana Luiza

机构信息

Division of Surgical Oncology, Department of Surgery, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA.

Division of Vascular Surgery, Department of Surgery, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA.

出版信息

J Gastrointest Oncol. 2024 Dec 31;15(6):2748-2750. doi: 10.21037/jgo-24-752. Epub 2024 Dec 11.

DOI:10.21037/jgo-24-752
PMID:39816013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11732345/
Abstract
摘要

相似文献

1
Combined hepatocellular carcinoma-cholangiocarcinoma with sarcomatoid features: new insights into a rare and aggressive tumor.具有肉瘤样特征的肝细胞癌-胆管癌合并症：对一种罕见侵袭性肿瘤的新见解
J Gastrointest Oncol. 2024 Dec 31;15(6):2748-2750. doi: 10.21037/jgo-24-752. Epub 2024 Dec 11.
2
The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.肝细胞癌合并胆管细胞癌、肝细胞癌和肝内胆管细胞癌术后的临床特征和预后因素：倾向评分匹配分析。
Int J Med Sci. 2021 Jan 1;18(1):187-198. doi: 10.7150/ijms.50883. eCollection 2021.
3
[A 42-month disease free survival case of combined hepatocellular-cholangiocarcinoma with lymph node metastases treated with multimodal therapy].[多模式治疗的合并肝细胞胆管癌伴淋巴结转移患者的42个月无病生存病例]
Gan To Kagaku Ryoho. 2006 Nov;33(12):1941-3.
4
[A case of sarcomatoid combined hepatocellular-cholangiocarcinoma].[1例肉瘤样型肝细胞胆管癌合并病例]
Korean J Gastroenterol. 2004 Jan;43(1):56-60.
5
Clinical features and outcomes of combined hepatocellular carcinoma and cholangiocarcinoma versus hepatocellular carcinoma versus cholangiocarcinoma after surgical resection: a propensity score matching analysis.联合肝细胞癌和胆管细胞癌与肝细胞癌和胆管细胞癌患者术后临床特征和结局的比较：倾向评分匹配分析。
BMC Gastroenterol. 2021 Jan 7;21(1):20. doi: 10.1186/s12876-020-01586-4.
6
Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.肝细胞癌-胆管癌、肝细胞癌及肝内胆管癌联合切除术后的结果
J Gastrointest Surg. 2016 Feb;20(2):411-20. doi: 10.1007/s11605-015-3045-3. Epub 2015 Dec 1.
7
Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.肝细胞癌合并胆管癌与肝细胞癌及肝内胆管癌的比较。
Surg Today. 2006;36(10):892-7. doi: 10.1007/s00595-006-3276-8.
8
Is the outcome after hepatectomy for transitional hepatocholangiocarcinoma different from that of hepatocellular carcinoma and mass-forming cholangiocarcinoma? A case-matched analysis.过渡型肝门部胆管细胞癌行肝切除术的预后是否与肝细胞癌和肿块型胆管细胞癌不同？一项病例匹配分析。
Updates Surg. 2020 Sep;72(3):671-679. doi: 10.1007/s13304-020-00802-w. Epub 2020 May 22.
9
Management of combined hepatocellular and cholangiocarcinoma.肝细胞癌合并胆管癌的管理
Int J Clin Pract. 2008 Aug;62(8):1271-8. doi: 10.1111/j.1742-1241.2007.01694.x. Epub 2008 Feb 13.
10
Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.15例肝细胞癌合并胆管癌患者的临床病理特征
Hepatobiliary Pancreat Dis Int. 2007 Apr;6(2):161-5.

本文引用的文献

1
Sarcomatoid change in combined hepatocellular carcinoma and cholangiocarcinoma as a poor prognostic factor.肝细胞癌合并胆管癌中的肉瘤样改变作为一个预后不良因素。
J Gastrointest Oncol. 2024 Aug 31;15(4):1796-1804. doi: 10.21037/jgo-24-313. Epub 2024 Aug 22.
2
Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.肝内胆管癌准确的淋巴结分期需要充分的淋巴结清扫: 一项基于人群的研究。
Cancer Med. 2023 Apr;12(7):8184-8198. doi: 10.1002/cam4.5620. Epub 2023 Jan 16.
3
Hepatocellular-Cholangiocarcinoma Collision Tumors: An Update of Current Management Practices.肝细胞胆管细胞癌碰撞瘤：当前治疗实践的更新。
Am Surg. 2023 Jun;89(6):2685-2692. doi: 10.1177/00031348221124323. Epub 2022 Aug 27.
4
Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular Carcinoma.肝细胞癌五种罕见病理亚型的流行病学及临床特征
Front Oncol. 2022 Apr 8;12:864106. doi: 10.3389/fonc.2022.864106. eCollection 2022.
5
Long-Term Survival of Combined Hepatocellular-Cholangiocarcinoma: A Nationwide Study.联合型肝细胞胆管细胞癌的长期生存：一项全国性研究。
Oncologist. 2021 Oct;26(10):e1774-e1785. doi: 10.1002/onco.13893. Epub 2021 Jul 19.
6
Combined hepatocellular-cholangiocarcinoma: An update.肝细胞-胆管细胞癌联合型：最新进展
J Hepatol. 2021 May;74(5):1212-1224. doi: 10.1016/j.jhep.2021.01.035. Epub 2021 Feb 3.
7
Combining imaging and tumour biopsy improves the diagnosis of combined hepatocellular-cholangiocarcinoma.联合影像与肿瘤活检可提高混合性肝细胞肝癌胆管细胞癌的诊断。
Liver Int. 2019 Dec;39(12):2386-2396. doi: 10.1111/liv.14261. Epub 2019 Oct 20.
8
Prevalence and clinical significance of regional lymphadenectomy in patients with hepatocellular carcinoma.肝细胞癌患者区域淋巴结清扫术的患病率及临床意义
ANZ J Surg. 2019 Apr;89(4):393-398. doi: 10.1111/ans.15096. Epub 2019 Mar 11.
9
Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends.肝细胞癌-胆管细胞癌混合型：发病率和死亡率趋势的人群水平分析。
World J Surg Oncol. 2019 Feb 27;17(1):43. doi: 10.1186/s12957-019-1586-8.
10
Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers.与其他肝癌相比，肝细胞癌-胆管细胞癌混合癌的临床和病理特征。
J Gastroenterol Hepatol. 2019 Jun;34(6):1074-1080. doi: 10.1111/jgh.14547. Epub 2018 Dec 16.